172 related articles for article (PubMed ID: 37439102)
21. Cancer-Selective Bioreductive Chemotherapy Mediated by Dual Hypoxia-Responsive Nanomedicine upon Photodynamic Therapy-Induced Hypoxia Aggravation.
Zhu R; He H; Liu Y; Cao D; Yan J; Duan S; Chen Y; Yin L
Biomacromolecules; 2019 Jul; 20(7):2649-2656. PubMed ID: 31125209
[TBL] [Abstract][Full Text] [Related]
22. A hybrid metal-organic framework nanomedicine-mediated photodynamic therapy and hypoxia-activated cancer chemotherapy.
Jia Z; Gao Y; Ni J; Wu X; Mao Z; Sheng G; Zhu Y
J Colloid Interface Sci; 2023 Jan; 629(Pt B):379-390. PubMed ID: 36162395
[TBL] [Abstract][Full Text] [Related]
23. Enhanced photo-hypoxia-activated combination therapy traced by AIE photosensitizer and targeted by hyaluronic acid: Disulphide bond interference of detoxification barrier.
Ouyang F; Zhang X; Zhang L; Liu Y; Shuai Q
J Photochem Photobiol B; 2022 Sep; 234():112535. PubMed ID: 35930948
[TBL] [Abstract][Full Text] [Related]
24. A tumor pH-responsive autocatalytic nanoreactor as a H
Liu F; He T; Gong S; Shen M; Ma S; Huang X; Li L; Wang L; Wu Q; Gong C
Acta Biomater; 2022 Dec; 154():510-522. PubMed ID: 36241016
[TBL] [Abstract][Full Text] [Related]
25. Silk fibroin-capped metal-organic framework for tumor-specific redox dyshomeostasis treatment synergized by deoxygenation-driven chemotherapy.
Yu H; Li Y; Zhang Z; Ren J; Zhang L; Xu Z; Kang Y; Xue P
Acta Biomater; 2022 Jan; 138():545-560. PubMed ID: 34775125
[TBL] [Abstract][Full Text] [Related]
26. Copper peroxide coated upconversion nanoparticle modified with glucose oxidase for H
Hong Y; Tao Q; Liu YY; Wang Z; Wang H; Sun L
Dalton Trans; 2022 Aug; 51(30):11325-11334. PubMed ID: 35838196
[TBL] [Abstract][Full Text] [Related]
27. One-Pot Rapid Synthesis of Cu
Li Q; Yu J; Lin L; Zhu Y; Wei Z; Wan F; Zhang X; He F; Tian L
ACS Appl Mater Interfaces; 2023 Apr; 15(13):16482-16491. PubMed ID: 36972557
[TBL] [Abstract][Full Text] [Related]
28. Pillar[6]arene-Based Supramolecular Nanocatalysts for Synergistically Enhanced Chemodynamic Therapy by the Intracellular Cascade Reaction.
Liu X; Liu J; Meng C; Zhu P; Liu X; Qian J; Ling S; Zhang Y; Ling Y
ACS Appl Mater Interfaces; 2021 Nov; 13(45):53574-53585. PubMed ID: 34729975
[TBL] [Abstract][Full Text] [Related]
29. Nitric oxide-mediated regulation of mitochondrial protective autophagy for enhanced chemodynamic therapy based on mesoporous Mo-doped Cu
Zhou Z; Gao Z; Chen W; Wang X; Chen Z; Zheng Z; Chen Q; Tan M; Liu D; Zhang Y; Hou Z
Acta Biomater; 2022 Oct; 151():600-612. PubMed ID: 35953045
[TBL] [Abstract][Full Text] [Related]
30. H
Qiao L; Ou Y; Li L; Wu S; Guo Y; Liu M; Yu D; Chen Q; Yuan J; Wei C; Ou C; Li H; Cheng D; Yu Z; Li Z
J Nanobiotechnology; 2024 Apr; 22(1):205. PubMed ID: 38658965
[TBL] [Abstract][Full Text] [Related]
31. Near-infrared light triggered liposomes combining photodynamic and chemotherapy for synergistic breast tumor therapy.
Yang Y; Yang X; Li H; Li C; Ding H; Zhang M; Guo Y; Sun M
Colloids Surf B Biointerfaces; 2019 Jan; 173():564-570. PubMed ID: 30347383
[TBL] [Abstract][Full Text] [Related]
32. Programmable Therapeutic Nanodevices with Circular Amplification of H
Li J; Wei Z; Lin X; Zheng D; Wu M; Liu X; Liu J
Adv Healthc Mater; 2019 May; 8(10):e1801627. PubMed ID: 30945472
[TBL] [Abstract][Full Text] [Related]
33. Combinational phototherapy and hypoxia-activated chemotherapy favoring antitumor immune responses.
Ma B; Sheng J; Wang P; Jiang Z; Borrathybay E
Int J Nanomedicine; 2019; 14():4541-4558. PubMed ID: 31417257
[No Abstract] [Full Text] [Related]
34. Antagonism of buthionine sulfoximine cytotoxicity for human neuroblastoma cell lines by hypoxia is reversed by the bioreductive agent tirapazamine.
Yang B; Keshelava N; Anderson CP; Reynolds CP
Cancer Res; 2003 Apr; 63(7):1520-6. PubMed ID: 12670899
[TBL] [Abstract][Full Text] [Related]
35. Biomimetic nanoplatform with H
Fu LH; Wu XY; He J; Qi C; Lin J; Huang P
Acta Biomater; 2023 May; 162():44-56. PubMed ID: 36934891
[TBL] [Abstract][Full Text] [Related]
36. Engineering tumor-specific catalytic nanosystem for NIR-II photothermal-augmented and synergistic starvation/chemodynamic nanotherapy.
Zhou S; Xu J; Dai Y; Wei Y; Chen L; Feng W; Chen Y; Ni X
Biomater Res; 2022 Nov; 26(1):66. PubMed ID: 36435848
[TBL] [Abstract][Full Text] [Related]
37. Biodegradable Nanocatalyst with Self-Supplying Fenton-like Ions and H
Li W; Zhou X; Liu S; Zhou J; Ding H; Gai S; Li R; Zhong L; Jiang H; Yang P
ACS Appl Mater Interfaces; 2021 Nov; 13(43):50760-50773. PubMed ID: 34672620
[TBL] [Abstract][Full Text] [Related]
38. Anti-LDLR modified TPZ@Ce6-PEG complexes for tumor hypoxia-targeting chemo-/radio-/photodynamic/photothermal therapy.
Song C; Xu W; Wei Z; Ou C; Wu J; Tong J; Cai Y; Dong X; Han W
J Mater Chem B; 2020 Jan; 8(4):648-654. PubMed ID: 31898718
[TBL] [Abstract][Full Text] [Related]
39. A dual-response drug delivery system with X-ray and ROS to boost the anti-tumor efficiency of TPZ
Han P; Zhang L; Fu Y; Fu Y; Huang J; He J; Ni P; Khan T; Jiao Y; Yang Z; Zhou R
Nanoscale; 2022 Dec; 15(1):237-247. PubMed ID: 36472214
[TBL] [Abstract][Full Text] [Related]
40. Multifunctional Theranostic Liposomes Loaded with a Hypoxia-Activated Prodrug for Cascade-Activated Tumor Selective Combination Therapy.
Dai Y; Wang B; Sun Z; Cheng J; Zhao H; Wu K; Sun P; Shen Q; Li M; Fan Q
ACS Appl Mater Interfaces; 2019 Oct; 11(43):39410-39423. PubMed ID: 31578854
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]